197 related articles for article (PubMed ID: 19243823)
1. Simultaneous engagement of FcgammaIIb and CD22 inhibitory receptors silences targeted B cells and suppresses autoimmune disease activity.
Mihaylova N; Voynova E; Tchorbanov A; Dolashka-Angelova P; Bayry J; Devreese B; Kaveri S; Vassilev T
Mol Immunol; 2009 Nov; 47(1):123-30. PubMed ID: 19243823
[TBL] [Abstract][Full Text] [Related]
2. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice.
Tchorbanov AI; Voynova EN; Mihaylova NM; Todorov TA; Nikolova M; Yomtova VM; Chiang BL; Vassilev TL
Eur J Immunol; 2007 Dec; 37(12):3587-96. PubMed ID: 18034421
[TBL] [Abstract][Full Text] [Related]
3. Selective silencing of autoreactive B lymphocytes-Following the Nature's way.
Nikolova KA; Mihaylova NM; Voynova EN; Tchorbanov AI; Voll RE; Vassilev TL
Autoimmun Rev; 2010 Sep; 9(11):775-9. PubMed ID: 20601201
[TBL] [Abstract][Full Text] [Related]
4. Selective silencing of disease-associated B-lymphocytes by chimeric molecules targeting their Fc gamma IIb receptor.
Mihaylova N; Voynova E; Tchorbanov A; Nikolova M; Michova A; Todorov T; Srebreva L; Taskov H; Vassilev T
Int Immunol; 2008 Feb; 20(2):165-75. PubMed ID: 18156625
[TBL] [Abstract][Full Text] [Related]
5. An antibody-based construct carrying DNA-mimotope and targeting CR1(CD35) selectively suppresses human autoreactive B-lymphocytes.
Voynova E; Tchorbanov A; Prechl J; Nikolova M; Baleva M; Erdei A; Vassilev T
Immunol Lett; 2008 Mar; 116(2):168-73. PubMed ID: 18262286
[TBL] [Abstract][Full Text] [Related]
6. Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity.
Dimitrova I; Gesheva V; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Lupus; 2010 Oct; 19(11):1261-71. PubMed ID: 20530521
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic control of B cell activation via recruitment of Fcgamma receptor IIb (CD32B) inhibitory function with a novel bispecific antibody scaffold.
Veri MC; Burke S; Huang L; Li H; Gorlatov S; Tuaillon N; Rainey GJ; Ciccarone V; Zhang T; Shah K; Jin L; Ning L; Minor T; Moore PA; Koenig S; Johnson S; Bonvini E
Arthritis Rheum; 2010 Jul; 62(7):1933-43. PubMed ID: 20506263
[TBL] [Abstract][Full Text] [Related]
8. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
9. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of antigenic potency in vitro and immunogenicity in vivo by coupling the antigen to anti-immunoglobulin.
Kawamura H; Berzofsky JA
J Immunol; 1986 Jan; 136(1):58-65. PubMed ID: 3079611
[TBL] [Abstract][Full Text] [Related]
11. Re-establishing tolerance to DNA in humanized and murine models of SLE.
Nikolova K; Mihaylova N; Voynova E; Kerekov N; Gesheva V; Prechl J; Nikolova M; Tchorbanov A
Autoimmun Rev; 2010 May; 9(7):499-502. PubMed ID: 20149897
[TBL] [Abstract][Full Text] [Related]
12. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
13. Suppression of dsDNA-specific B lymphocytes reduces disease symptoms in SCID model of mouse lupus.
Gesheva V; Kerekov N; Nikolova K; Mihaylova N; Todorov T; Nikolova M; Tchorbanov A
Autoimmunity; 2014 May; 47(3):162-72. PubMed ID: 24502777
[TBL] [Abstract][Full Text] [Related]
14. The same epitope on CD22 of B lymphocytes mediates the adhesion of erythrocytes, T and B lymphocytes, neutrophils, and monocytes.
Engel P; Nojima Y; Rothstein D; Zhou LJ; Wilson GL; Kehrl JH; Tedder TF
J Immunol; 1993 Jun; 150(11):4719-32. PubMed ID: 7684411
[TBL] [Abstract][Full Text] [Related]
15. Peripheral B cell receptor editing may promote the production of high-affinity autoantibodies in CD22-deficient mice.
Yarkoni Y; Fischel R; Kat I; Yachimovich-Cohen N; Eilat D
Eur J Immunol; 2006 Oct; 36(10):2755-67. PubMed ID: 16983722
[TBL] [Abstract][Full Text] [Related]
16. CD22 serves as a receptor for soluble IgM.
Adachi T; Harumiya S; Takematsu H; Kozutsumi Y; Wabl M; Fujimoto M; Tedder TF
Eur J Immunol; 2012 Jan; 42(1):241-7. PubMed ID: 21956693
[TBL] [Abstract][Full Text] [Related]
17. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
[TBL] [Abstract][Full Text] [Related]
18. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
[TBL] [Abstract][Full Text] [Related]
19. Class-specific regulation of anti-DNA antibody synthesis and the age-associated changes in (NZB x NZW)F1 hybrid mice.
Sekigawa I; Okada T; Noguchi K; Ueda G; Hirose S; Sato H; Shirai T
J Immunol; 1987 May; 138(9):2890-5. PubMed ID: 2952727
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of anti-IgM and growth factor-induced proliferation of guinea pig B cells by one of two distinct Fc gamma receptors on the cells.
Yamashita T; Koyama J
J Immunol; 1988 Nov; 141(9):2889-94. PubMed ID: 2971734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]